Cargando…

An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients

BACKGROUND: This study aimed to identify autophagy-related long non-coding RNAs (lncRNAs) associated with progression of neuroblastoma (NB), and to build an autophagy-related lncRNA signature that helps to predict progression-free survival (PFS) of NB. METHODS: Three independent gene expression data...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Meng, Xinyao, Chen, Ke, Feng, Jiexiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753905/
https://www.ncbi.nlm.nih.gov/pubmed/36530992
http://dx.doi.org/10.3389/fonc.2022.1014845
_version_ 1784851070535598080
author Wang, Jing
Meng, Xinyao
Chen, Ke
Feng, Jiexiong
author_facet Wang, Jing
Meng, Xinyao
Chen, Ke
Feng, Jiexiong
author_sort Wang, Jing
collection PubMed
description BACKGROUND: This study aimed to identify autophagy-related long non-coding RNAs (lncRNAs) associated with progression of neuroblastoma (NB), and to build an autophagy-related lncRNA signature that helps to predict progression-free survival (PFS) of NB. METHODS: Three independent gene expression datasets were utilized in this study. Autophagy-related genes (ARG) associated with PFS of NB patients were firstly identified by univariate Cox survival analysis. lncRNAs correlated with those PFS-related ARGs were then identified. The least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression analyses were performed to select out those lncRNAs with the best prognostic value for PFS. The Receiver Operating Characteristic (ROC) and Area Under Curve (AUC) analyses were performed to assess the prediction accuracy. RESULTS: Four autophagy-related lncRNAs (AL356599.1, AC022075.1, AC020928.1 and LINC02076) were found to be with the best prognostic value and integrated into a four-lncRNA risk signature for predicting PFS of NB patients. The four-lncRNA signature significantly stratify NB patients into two risk groups, with high-risk group has significantly poorer PFS than the low-risk group. The prognostic role of the lncRNA signature was independent with other clinical risk factors. The ROC curves revealed that the lncRNA signature has a good performance in predicting PFS (AUC > 0.70). A nomogram based on COG (Children’s Oncology Group) risk and the lncRNA risk score was constructed, showing good prediction accuracy (C-index = 0.700). The prognostic ability of the nomogram was better than that of COG risk alone (AUC = 0.790 versus AUC = 0.748). GSEA analyses revealed that multiple autophagy-related gene sets are significantly enriched in the low-risk group. CONCLUSIONS: We identified an autophagy-related four-lncRNA signature that could help to predict the PFS of NB patients. Autophagy-related gene sets are significantly enriched in low-risk group, suggesting tumor suppressive roles of autophagy in NB.
format Online
Article
Text
id pubmed-9753905
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97539052022-12-16 An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients Wang, Jing Meng, Xinyao Chen, Ke Feng, Jiexiong Front Oncol Oncology BACKGROUND: This study aimed to identify autophagy-related long non-coding RNAs (lncRNAs) associated with progression of neuroblastoma (NB), and to build an autophagy-related lncRNA signature that helps to predict progression-free survival (PFS) of NB. METHODS: Three independent gene expression datasets were utilized in this study. Autophagy-related genes (ARG) associated with PFS of NB patients were firstly identified by univariate Cox survival analysis. lncRNAs correlated with those PFS-related ARGs were then identified. The least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression analyses were performed to select out those lncRNAs with the best prognostic value for PFS. The Receiver Operating Characteristic (ROC) and Area Under Curve (AUC) analyses were performed to assess the prediction accuracy. RESULTS: Four autophagy-related lncRNAs (AL356599.1, AC022075.1, AC020928.1 and LINC02076) were found to be with the best prognostic value and integrated into a four-lncRNA risk signature for predicting PFS of NB patients. The four-lncRNA signature significantly stratify NB patients into two risk groups, with high-risk group has significantly poorer PFS than the low-risk group. The prognostic role of the lncRNA signature was independent with other clinical risk factors. The ROC curves revealed that the lncRNA signature has a good performance in predicting PFS (AUC > 0.70). A nomogram based on COG (Children’s Oncology Group) risk and the lncRNA risk score was constructed, showing good prediction accuracy (C-index = 0.700). The prognostic ability of the nomogram was better than that of COG risk alone (AUC = 0.790 versus AUC = 0.748). GSEA analyses revealed that multiple autophagy-related gene sets are significantly enriched in the low-risk group. CONCLUSIONS: We identified an autophagy-related four-lncRNA signature that could help to predict the PFS of NB patients. Autophagy-related gene sets are significantly enriched in low-risk group, suggesting tumor suppressive roles of autophagy in NB. Frontiers Media S.A. 2022-12-01 /pmc/articles/PMC9753905/ /pubmed/36530992 http://dx.doi.org/10.3389/fonc.2022.1014845 Text en Copyright © 2022 Wang, Meng, Chen and Feng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Jing
Meng, Xinyao
Chen, Ke
Feng, Jiexiong
An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_full An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_fullStr An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_full_unstemmed An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_short An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
title_sort autophagy-related four-lncrna signature helps to predict progression-free survival of neuroblastoma patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753905/
https://www.ncbi.nlm.nih.gov/pubmed/36530992
http://dx.doi.org/10.3389/fonc.2022.1014845
work_keys_str_mv AT wangjing anautophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT mengxinyao anautophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT chenke anautophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT fengjiexiong anautophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT wangjing autophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT mengxinyao autophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT chenke autophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients
AT fengjiexiong autophagyrelatedfourlncrnasignaturehelpstopredictprogressionfreesurvivalofneuroblastomapatients